Thus, MSI2 is highly associated with epithelial‒mesenchymal transition (EMT) in NSCLC, and its regulation of transforming growth factor‐beta (TGF‐β) and inhibition of claudins ultimately promote the invasive metastasis of NSCLC.22, 24. This evidence concerns the gene MSI2 and non-small cell lung carcinoma.